P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,560.00
+10.00 (0.39%)
At close: Apr 28, 2026
15.84%
Market Cap 73.94B
Revenue (ttm) 22.78B
Net Income (ttm) 4.69B
Shares Out 28.88M
EPS (ttm) 162.22
PE Ratio 15.78
Forward PE n/a
Dividend 50.00 (1.95%)
Ex-Dividend Date Dec 29, 2025
Volume 89,788
Average Volume 116,770
Open 2,550.00
Previous Close 2,550.00
Day's Range 2,540.00 - 2,620.00
52-Week Range 1,996.00 - 3,300.00
Beta 0.76
RSI 71.49
Earnings Date May 15, 2026

About P&K Skin Research Center

P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for new cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vitro tests. It also manufactures and sells raw pharmaceutical and cosmetic materials, and raw materials for health foods. The company was founded in 201... [Read more]

Industry Commercial Physical and Biological Research
Founded 2010
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 347740
Full Company Profile

Financial Performance

In 2025, P&K Skin Research Center's revenue was 22.78 billion, an increase of 27.66% compared to the previous year's 17.85 billion. Earnings were 4.69 billion, a decrease of -19.45%.

Financial Statements

News

There is no news available yet.